|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
enhances cardiac contractility and protects against infarction-induced heart failure
1 Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
2 Pediatrics, Cincinnati Children's Hospital Medical Center, cincinnati, Ohio, United States
3 Molecular and Cellular Physiology, University of Cincinnati, Cincinnati, Ohio, United States
* To whom correspondence should be addressed. E-mail: Molkj0{at}chmcc.org.
Mice null for the gene encoding protein kinase C
(Prkca), or mice treated with pharmacologic inhibitors of the PKC
/
/
isoforms, show an augmentation in cardiac contractility that appears to be cardioprotective. However, it remains uncertain if PKC
itself functions in a myocyte autonomous manner to effect cardioprotection in vivo. Here we generated cardiac myocyte-specific transgenic mice using a tetracycline-inducible system to permit controlled expression of dominant negative (dn) PKC
in the heart. Consistent with the proposed function of PKC
, induction of dnPKC
expression in the adult heart enhanced baseline cardiac contractility. This increase in cardiac contractility was associated with a partial protection from long-term decompensation and secondary dilated cardiomyopathy following myocardial infarction (MI) injury. Similarly, Prkca null mice were also partially protected from infarction-induced heart failure, although the area of infarction injury was identical to controls. Thus, myocyte autonomous inhibition of PKC
protects the adult heart from decompensation and dilated cardiomyopathy following infarction injury, in association with a primary enhancement in contractility.
This article has been cited by other articles:
![]() |
C. Hidalgo, B. Hudson, J. Bogomolovas, Y. Zhu, B. Anderson, M. Greaser, S. Labeit, and H. Granzier PKC Phosphorylation of Titin's PEVK Element: A Novel and Conserved Pathway for Modulating Myocardial Stiffness Circ. Res., September 25, 2009; 105(7): 631 - 638. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Liu, X. Chen, S. M. MacDonnell, E. G. Kranias, J. N. Lorenz, M. Leitges, S. R. Houser, and J. D. Molkentin Protein Kinase C{alpha}, but Not PKC{beta} or PKC{gamma}, Regulates Contractility and Heart Failure Susceptibility: Implications for Ruboxistaurin as a Novel Therapeutic Approach Circ. Res., July 17, 2009; 105(2): 194 - 200. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Koyanagi, L. Y. Wong, K. Inagaki, O. V. Petrauskene, and D. Mochly-Rosen Alteration of gene expression during progression of hypertension-induced cardiac dysfunction in rats Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H220 - H226. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |